* GENOSCIENCE PHARMA *
2001 - Méditerranée Marseille www.genosciencepharma.com Discovery, Drugs (also, Contract, Research) Key words: Antivirals, Predict-Search, GenMol, Protease inhibitor, HCV Mission: to develop new drugs for the treatment of viral diseases and the identification of molecular markers to monitor antiviral therapies and to answer the problem of microarray interpretation, by using PredictSearch, a proprietary powerful data mining based software Clients: Pharmaceutical industry namrani@3dgenoscience.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture | Managing Dir.: (interim) Halfon (Philippe) [founder, born 1960, M.D., Ph.D., Alphabio (CEO)] Sc.Dir.: Benech (Philippe) [Ph.D., ex-CNRS] Fin.Dir.: BusDev: Financers: | Turnover (M€) : 0.015 (2006) Total funding (M€) : n.a. Last funding (M€) : n.a. Focus : Virus Position : Preclin Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2006 .11 | Acquisition of Genosedi, a bio-informatics venture | ACQ+ | [5 years] |
| 2001 .08 | Company founded by Prof. Philippe Halfon | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|